iiinova — where your digital self keeps evolving

Reposted by Jean-Guillaume Letarouilly

ero.eular.org @ero.eular.org · 05/06/2026

"What if medical education could inspire people and not only inform them?" Brilliant presentation by @cristianasieiro.bsky.social on RheumaVision at #EULAR2026 in London. Community co-creation is the future! 🏥✨

052

Reposted by Jean-Guillaume Letarouilly

ero.eular.org @ero.eular.org · 05/06/2026

A very unique @EMEUNET session at #EULAR26 Gamification for education ⚽ Engagement is essential for education 🔑 Information is everywhere 💻 Experience helps remember information 🧠

042

Reposted by Jean-Guillaume Letarouilly

ero.eular.org @ero.eular.org · 04/06/2026

📊 New data from the SPACE cohort evaluates the 2025 ASAS-SPARTAN #axSpA criteria! The revised sets prioritise specificity (💥 all >94% regardless of reader). 📉 However, massive drop-off in sensitivity. For local readers, 83.0% (2009 criteria) down to just 60.2%. #EULAR2026 #OP0239

155

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 04/06/2026

Direct from #EULAR2026 ▶️Perimenopause is associated with increased disease activity in PsA ▶️Rheumatologists should be aware of possible flares of PSA during peri-menopause ➡️ Research is needed to understand the effect of sex-effect in different life stages of PsA

052

Reposted by Jean-Guillaume Letarouilly

ero.eular.org @ero.eular.org · 04/06/2026

043

Reposted by Jean-Guillaume Letarouilly

ero.eular.org @ero.eular.org · 03/06/2026

Sitting in on the WIN Psoriatic Arthritis plenary session right now! 🩺✨ Fascinating presentation on stage from Dennis McGonagle diving into new data on how Lipopolysaccharide + JAK inhibition increases clot formation in vitro in RA 🧬📊.

111

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 02/06/2026

🎉 Meet the brilliant ARD & ERO Guest Social Media Editors for #EULAR2026! 🚀 Say hello to Jelena, Ertuğrul, Mariana, Guillermo, Rúben, Daliya, & Elvis! They’ll be bringing you the best insights straight from the congress.

054

Reposted by Jean-Guillaume Letarouilly

ero.eular.org @ero.eular.org · 02/06/2026

041

Jean-Guillaume Letarouilly @jgletarouilly.bsky.social · 22/10/2025

🚨New Publication Alert for Clinicians! 🚨 Do your IBD, RA, or Spondyloarthritis patients need skin cancer screening? Our Joint Bone Spine review proposes a pragmatic algorithm to identify IMID patients at increased risk. 👇 authors.elsevier.com/a/1luf0,TVsH...

000

Jean-Guillaume Letarouilly @jgletarouilly.bsky.social · 12/09/2025

🎓✨ Honoured to be appointed Associate Professor in Rheumatology at @chulille.bsky.social @ufr3s-ulille.bsky.social 🙏 Grateful to keep caring for patients, advancing research in chronic inflammatory diseases (esp. spondyloarthritis) & teaching future clinicians. Thanks to all who supported me!

010

Jean-Guillaume Letarouilly @jgletarouilly.bsky.social · 24/06/2025

🎓 Congratulations to Astrid Goudot for her outstanding medical thesis defence in both 🇫🇷🇬🇧 on predictive factors of D2T PsA in patients initiating their 1st bDMARD. 👏👏 Many thanks to Laura Coates who shared her valuable expertise on this timely topic 🌍👏

120

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 14/06/2025

🧪 Late-breaking APEX trial results! In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed: 🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001) 💪 Higher ACR20 responses #EULAR2025 Posted by @jgletarouilly.bsky.social

032

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 13/06/2025

🧬 Does MTX with 1st ADA shot prevent anti-ADA antibodies in axSpA? 🇫🇷 MESYNAD RCT: ❌ No difference at 6mo 💉 MTX+ADA = ADA alone No added benefit for immunogenicity. #EULAR2025 #POS0889 Posted by @jgletarouilly.bsky.social

042

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 12/06/2025

Gaslighting and Unconscious Bias in Rheumatology , a powerful session at #EULAR2025 exposing the harm caused within and beyond clinical teams. Disagree Well. Speak truth. Challenge bias. #Gaslighting #UnconsciousBias #EULAR2025 IH

062

Reposted by Jean-Guillaume Letarouilly

Thomas Davergne @thomasdavergne.bsky.social · 12/06/2025

📲 Inspiring work from Deniz Bayraktar at #EULAR2025! She adapted the SARAH self-rehab programme for people with RA in Türkiye — and delivered it via WhatsApp! 🇹🇷💬 A brilliant example of accessible care in action.

074

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 12/06/2025

📊 RABBIT-SpA registry insights: 🔹 8.5% met ASAS D2M axSpA criteria (75/881) 🔹 2.5% met TR criteria (22/881) 👩 D2M-axSpA patients = more female, less HLA-B27 Results similar to those from the Dutch cohort #EULAR2025 Posted by @jgletarouilly.bsky.social

042

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 12/06/2025

🧠✨GRAPPA Definitions 🔹Complex-to-Manage PsA (C2M PsA) ➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊 🔸 Difficult-to-Treat PsA (D2T PsA) ➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥 #EULAR2025 Posted by @jgletarouilly.bsky.social

042

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 12/06/2025

🔬SPEED RCT in patients with PsA and poor prognostic factors 🎯 Primary Endpoint: Mean PASDAS at 24 weeks ✅ Combination csDMARDs** > Standard step-up ✅️TNFi** > Standard step-up ❌ No significant difference between Combination csDMARDs and TNFi #EULAR2025 Posted by @jgletarouilly.bsky.social

052

Jean-Guillaume Letarouilly @jgletarouilly.bsky.social · 11/06/2025

🌟Thrilled and honoured to join @ard.eular.org as a guest Social Media Editor for #EULAR2025!🥳Thank you @alessiaalunno.bsky.social for the trust and support! Looking forward to sharing insights and highlights from this exciting congress. 🙌✨

020

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 11/06/2025

Good morning Barcelona! We are fully operational onsite at #EULAR2025 with an enthusiastic team of guest Social Media Editors. 👉🏻Follow along for live updates!

084

Reposted by Jean-Guillaume Letarouilly

The European Alliance of Associations for Rheumatology @eular.org · 09/06/2025

Make the most of #EULAR2025 with the official Congress App! 🗺️ Navigate the 4-day event with ease, find session info, symposia, exhibition highlights, and venue services. 🗓️ Build your personal schedule 📱Download the EULAR 2025 Congress App and elevate your experience! #rheumatology

082

Reposted by Jean-Guillaume Letarouilly

Annals of the Rheumatic Diseases @ard.eular.org · 03/06/2025

📢 Welcome to the ARD BlueSky Channel! 👉🏻 Follow along for the latest updates on published articles and more! 🎤 Stay tuned also for live coverage from #EULAR2025 Congress taking place in Barcelona on 11-14 June 2025. 📖 Browse the journal at www.sciencedirect.com/journal/anna...

sciencedirect.com

Annals of the Rheumatic Diseases | Journal | ScienceDirect.com by ElsevierScienceDirect

Read the latest articles of Annals of the Rheumatic Diseases at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

072

Reposted by Jean-Guillaume Letarouilly

Cristiana Sieiro Santos @cristianasieiro.bsky.social · 30/05/2025

🎙️ New EMEUNET #Podcast! ✨ RheumaVision 2025 Explained 🎥 How was #RheumaVision created? What's coming at #EULAR2025? 🚀 Join Renske, @jgletarouilly.bsky.social @TueKragstrup & me for a behind-the-scenes look! 🎧 Listen here 👉 open.spotify.com/episode/1TFg7j…

052

Jean-Guillaume Letarouilly @jgletarouilly.bsky.social · 23/05/2025

Look forward to chairing with you this exciting final of #RheumaVision! Our 6 finalists will present their topics to a prestigious jury: Denis Poddubnyy, Jette Primdahl, Caroline Ospelt and Simon Stones. Audience vote will be essential so join us! 🎉

020

Reposted by Jean-Guillaume Letarouilly

Cristiana Sieiro Santos @cristianasieiro.bsky.social · 23/05/2025

We’re proud to reveal the #RheumaVision 2025 FINALISTS! 🎉 Brilliant early career rheumatologists sharing science through storytelling 🎥✨ Catch them at the Grand Finale during #EULAR2025 in Barcelona 🇪🇸 @jgletarouilly.bsky.social @eular.org @emeunet

042